dc.contributor.author | Özdemir, Ahmet | |
dc.contributor.author | Altıntop, Mehlika Dilek | |
dc.contributor.author | Kaplancıklı, Zafer Asım | |
dc.contributor.author | Turan, Gülhan | |
dc.contributor.author | Çiftçi, Gülsen Akalın | |
dc.contributor.author | Yıldırım, Şafak Ulusoylar | |
dc.date.accessioned | 2019-10-19T14:44:38Z | |
dc.date.available | 2019-10-19T14:44:38Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 1475-6366 | |
dc.identifier.issn | 1475-6374 | |
dc.identifier.uri | https://dx.doi.org/10.3109/14756366.2012.724682 | |
dc.identifier.uri | https://hdl.handle.net/11421/13573 | |
dc.description | WOS: 000326745800013 | en_US |
dc.description | PubMed ID: 23020635 | en_US |
dc.description.abstract | In the present study, 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives (1-6) were synthesized via the ring closure reaction of 1-(2-thienyl)-3-aryl-2-propen-1-ones with hydrazine hydrate in acetic acid. The chemical structures of the compounds were elucidated by IR, H-1-NMR, C-13-NMR and mass spectral data and elemental analyses. MTT assay, analysis of DNA synthesis and caspase-3 activation assay were carried out to determine anticancer effects of the compounds on A549 and C6 cancer cell lines. They exhibited dose-dependent anticancer activity against A549 and C6 cancer cell lines. Anticancer activity screening results revealed that compounds 1, 2 and 4 were the most potent derivatives among these compounds. But anticancer effects of these compounds may result from different death mechanisms in A549 and C6 cell lines. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Informa Healthcare | en_US |
dc.relation.isversionof | 10.3109/14756366.2012.724682 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pyrazoline | en_US |
dc.subject | Anticancer Activity | en_US |
dc.subject | Mtt Assay | en_US |
dc.subject | Caspase-3 Activation | en_US |
dc.title | Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity | en_US |
dc.type | article | en_US |
dc.relation.journal | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.contributor.department | Anadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı | en_US |
dc.identifier.volume | 28 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 1221 | en_US |
dc.identifier.endpage | 1227 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.contributor.institutionauthor | Özdemir, Ahmet | |
dc.contributor.institutionauthor | Altıntop, Mehlika Dilek | |
dc.contributor.institutionauthor | Kaplancıklı, Zafer Asım | |
dc.contributor.institutionauthor | Turan, Gülhan | |
dc.contributor.institutionauthor | Çiftçi, Gülsen Akalın | |